Publications

Breast cancer research : BCR

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

29-12-2024

Frontiers in immunology

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system.

24-12-2024

Proceedings of the National Academy of Sciences of the United States of America

An antibiotic that mediates immune destruction of senescent cancer cells.

24-12-2024

Genome research

Characterization of DNA methylation reader proteins in Arabidopsis thaliana.

23-12-2024

STAR protocols

Protocol for studying macrophage lipid crosstalk with murine tumor cells.

20-12-2024

Molecular cell

STK19 drives transcription-coupled repair by stimulating repair complex stability, RNA Pol II ubiquitylation, and TFIIH recruitment.

19-12-2024

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Metastatic breast cancer patients' preferences for exercise programs: a latent class analysis using data from a survey in five European countries.

18-12-2024

Cell systems

Optimized reporters for multiplexed detection of transcription factor activity.

18-12-2024

The Journal of infectious diseases

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa.

16-12-2024

Pharmaceuticals (Basel, Switzerland)

A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.

14-12-2024

Science advances

Transcription processes compete with loop extrusion to homogenize promoter and enhancer dynamics.

13-12-2024

Nucleic acids research

Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer.

11-12-2024

Cancer cell

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy.

09-12-2024

Signal transduction and targeted therapy

Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial.

09-12-2024

Cancer cell

Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade.

09-12-2024

Prostate cancer and prostatic diseases

Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.

05-12-2024

Cancer discovery

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.

02-12-2024

Clinical cancer research : an official journal of the American Association for Cancer Research

Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.

02-12-2024

Bladder cancer (Amsterdam, Netherlands)

Systemic induction therapy in patients with locally advanced or node-positive urothelial carcinoma: Evaluating treatment outcomes.

01-12-2024

Nature reviews. Immunology

Defining myeloid-derived suppressor cells.

01-12-2024

Cancer treatment reviews

Local administration of immunotherapy for patients with skin cancer: A systematic review.

01-12-2024

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial.

01-12-2024

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer.

01-12-2024

European urology focus

Advancements in the front-line treatment of metastatic urothelial carcinoma.

01-12-2024

Environmental toxicology and pharmacology

Compound-dependent fetal toxicity after in utero exposure to chemotherapy in a pregnant mouse model.

01-12-2024

Clinical pharmacokinetics

A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.

01-12-2024

European journal of nuclear medicine and molecular imaging

Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [¹⁸F]FDG PET/CT: a systematic review and individual patient data meta-analysis.

01-12-2024

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index.

01-12-2024

Future science OA

DNA sequencing in oncology: a focus group study on a duty to recontact.

01-12-2024

Lasers in surgery and medicine

Imaging Photoplethysmography (iPPG) in Head and Neck Reconstructive Surgery: A Novel Technique for Noninvasive Flap Perfusion Monitoring.

01-12-2024

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.

01-12-2024

European journal of cancer (Oxford, England : 1990)

Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study.

01-12-2024

JCO clinical cancer informatics

Actionability of Synthetic Data in a Heterogeneous and Rare Health Care Demographic: Adolescents and Young Adults With Cancer.

01-12-2024

The Lancet. Oncology

Capturing the true effect of anti-PD-1 therapy on patients' health-related quality of life.

01-12-2024

European journal of nuclear medicine and molecular imaging

Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication.

01-12-2024

Annals of hematology

Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry.

01-12-2024

European radiology

Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer.

01-12-2024

Nature protocols

Quantifying genome-wide transcription factor binding affinities for chromatin using BANC-seq.

01-12-2024

Current opinion in genetics & development

Better together: how cooperativity influences transcriptional bursting.

01-12-2024

Lung cancer (Amsterdam, Netherlands)

Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort.

01-12-2024

Journal of the National Cancer Institute

Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.

01-12-2024

Breast (Edinburgh, Scotland)

Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study.

01-12-2024

Future oncology (London, England)

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

01-12-2024

Annals of oncology : official journal of the European Society for Medical Oncology

Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.

01-12-2024

Journal of magnetic resonance imaging : JMRI

AI Applications to Breast MRI: Today and Tomorrow.

01-12-2024

Haematologica

IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia.

01-12-2024

ESMO open

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial.

01-12-2024

Biopreservation and biobanking

The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks.

01-12-2024

The Journal of molecular diagnostics : JMD

High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue.

01-12-2024

Biomedical optics express

Tissue-probe contact assessment during robotic surgery using single-fiber reflectance spectroscopy.

01-12-2024

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system.

An antibiotic that mediates immune destruction of senescent cancer cells.

Characterization of DNA methylation reader proteins in Arabidopsis thaliana.

Protocol for studying macrophage lipid crosstalk with murine tumor cells.

STK19 drives transcription-coupled repair by stimulating repair complex stability, RNA Pol II ubiquitylation, and TFIIH recruitment.

Metastatic breast cancer patients' preferences for exercise programs: a latent class analysis using data from a survey in five European countries.

Optimized reporters for multiplexed detection of transcription factor activity.

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa.

A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.

Transcription processes compete with loop extrusion to homogenize promoter and enhancer dynamics.

Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer.

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy.

Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial.

Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade.

Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.

Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.

Systemic induction therapy in patients with locally advanced or node-positive urothelial carcinoma: Evaluating treatment outcomes.

Defining myeloid-derived suppressor cells.

Local administration of immunotherapy for patients with skin cancer: A systematic review.

Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial.

Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer.

Advancements in the front-line treatment of metastatic urothelial carcinoma.

Compound-dependent fetal toxicity after in utero exposure to chemotherapy in a pregnant mouse model.

A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.

Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis.

Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index.

DNA sequencing in oncology: a focus group study on a duty to recontact.

Imaging Photoplethysmography (iPPG) in Head and Neck Reconstructive Surgery: A Novel Technique for Noninvasive Flap Perfusion Monitoring.

Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.

Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study.

Actionability of Synthetic Data in a Heterogeneous and Rare Health Care Demographic: Adolescents and Young Adults With Cancer.

Capturing the true effect of anti-PD-1 therapy on patients' health-related quality of life.

Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication.

Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry.

Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer.

Quantifying genome-wide transcription factor binding affinities for chromatin using BANC-seq.

Better together: how cooperativity influences transcriptional bursting.

Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort.

Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.

Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study.

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.

AI Applications to Breast MRI: Today and Tomorrow.

IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia.

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial.

The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks.

High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue.

Tissue-probe contact assessment during robotic surgery using single-fiber reflectance spectroscopy.

This site uses cookies

Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [¹⁸F]FDG PET/CT: a systematic review and individual patient data meta-analysis.